Boston Institute of Biotechnology, LLC
Exciting News: World’s first Ultra-large Bioreactor
We have the world’s first ultra large bioreactor with a 30K working volume capacity, and over 40K total volume! This bioreactor is part of a new generation of systems that are developed to help significantly decrease cost and increase speed to market, transforming your molecules into medicines that help patients in need!
We have just completed our large-scale CDMO base for biologics with a total capacity of over 200,000L. The project has a total construction area of 123,700 square meters, including the worlds largest 30,000L mammalian cell production line.
Construction Complete!
During Construction
Our Mission
To provide patients with high-quality, affordable biological medicines with our trusted and faithful partners.
We provide full spectrum CMC services
exceed expectations
- From Preclinical to GMP Production- As a fast-growing CDMO, our world-class experts provide full spectrum CMC services for biologics and gene therapy
- Microbial and Mammalian platforms- We have wide coverage for different services: process development, non-GMP production, process characterization, and GMP manufacturing
- Full-Scale Capacity- From micro matrix to large scale GMP bioreactor (2,000L), we have the full capability to serve your R&D and clinical needs
- Timely, High Quality & Competitive Price- BIB is a US-based, global company. With extensive experience, we can deliver high-quality results and shorten the timeline by 20% – 50%
130
Projects Completed
It takes a lot to be one of the most trusted CDMO partners. Read more below why customers keep coming back over and over again.
20
Years of Experience
Decades of working experience in world-leading CDMOs make our team one of the best choices for your CMC needs
